• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1993 Fiscal Year Final Research Report Summary

Generation of a new mouse model for transplantation of human cells by utilizing an anti-IL-2 receptor beta chain monoclonal antibody

Research Project

Project/Area Number 04558014
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Laboratory animal science
Research InstitutionTokyo Metropolitan Institute for Medical Science

Principal Investigator

MIYASAKA Masayuki  Tokyo Metropolitan Institute of Medical Science, Dept.Immunol., Head, 免疫研究部門, 研究員 (50064613)

Co-Investigator(Kenkyū-buntansha) NAWA Yukifumi  Miyazaki University Medical School Dept.Parasitol., Professor, 寄生虫学教室, 教授 (10040172)
UEYAMA Yoshihito  Tokai University Medical School Dept.Pathol., Associate Professor, 病理学教室, 助教授 (30072408)
URANO Kouji  Institute for Experimental Animals Research Scientist, 研究員 (80213510)
KITAMURA Fujiko  TMIMS, Dept.Immunol., Research Member, 免疫研究部門, 研究員 (90124453)
TANAKA Toshiyuki  TMIMS, Dept.Immunol., Research Member, 免疫研究部門, 研究員 (30217054)
Project Period (FY) 1992 – 1993
KeywordsIL-2 receptor beta chain / NK cell / SCID mouse / SCID-Hu
Research Abstract

By takeing advantage of the fact that natural killer (NK) cells can be eliminated specifically for long-term in vivo by a single i.p. injection of monoclonal antibody against IL-2 receptor beta chain (anti-IL-2Rbeta), we attempted to generate a mouss model in which various types of human cells can be readily transplanted. We found that injection of the anti-IL-2Rbeta into SCID mice induces long-term elimination of NK cells, thus generating T-, B- and NK-deficient mice. ATL cells that do not normally grow in untreated SCID mice did grow well in such antibody-treated NK-deficient SCID mice, raising an interesting possibility that this in vivo model can be used for screening and testing the efficacy of anti-ATL drug candidates. This antibody may be also be beneficial for generation of SCID-Hu.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Tanaka,T.,Kitamura,F.,Nagasaka,Y.,Kuida,K.,Suwa,H.and Miyasaka,M.: "Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice." The Journal of Experimental Medicine. 178. 1103-1107 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kondo,A.,Imada,K.,Hattori,T.,Yamabe,H.,Tanaka,T.,Miyasaka,M.,Okuma,M.and Uchiyama,T.: "A model of in vivo cell proliferation of adult T-cell leukemia." Blood. 82. 2501-2509 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 田中稔之: "T細胞およびNK細胞の発生におけるIL-2の役割" 臨床免疫. 24. 1637-1644 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 田中稔之: "Thy-1^+dECの発生とIL-2レセプターβ鎖" 免疫・Immunology Frontier. 2. 58-60 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 田中稔之: "上皮内γδT細胞の発生とサイトカイン-Thy-1^+dECとIL-2システムを中心にして-" 臨床免疫. 25. 778-783 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 田中稔之: "Dendritic epidermal T cells-IL-2レセプターβ鎖の発現-" Medical Immunology. 25. 57-63 (1993)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tanaka, T., Kitamura, F., Nagasaka, Y., Kuida, K., Suwa, H.and Miyasaka, M.: "Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice." J.Exp.Med.178. 1103-1107 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kondo, A., Imada, K., Hattori, T., Yamabe, H., Tanaka, T., Miyasaka, M., Okuma, M.and Uchiyama, T.: "A model of in vivo cell proliferation of adult T-cell leukemia." Blood. 82. 2501-2509 (1993)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1995-03-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi